Sale!

NOTCH3 Gene CADASIL NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The NOTCH3 Gene CADASIL NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the NOTCH3 gene responsible for CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy). This advanced next-generation sequencing test provides crucial information about hereditary cerebral small vessel disease that can lead to recurrent strokes, migraines, and cognitive impairment. For only $500 USD (discounted from $700), patients can access precise genetic analysis to understand their vascular disease risk. The test is particularly valuable for individuals with family history of early-onset strokes or unexplained neurological symptoms. Results typically take 3-4 weeks and require a simple blood sample or DNA extraction. Genetic counseling is recommended before testing to ensure proper interpretation and family risk assessment.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

NOTCH3 Gene CADASIL NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Cerebral Arteriopathy

The NOTCH3 Gene CADASIL NGS Genetic DNA Test represents a breakthrough in vascular genetics, offering precise detection of mutations associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This inherited condition affects the small blood vessels in the brain, leading to recurrent strokes, cognitive decline, and neurological complications. Our advanced next-generation sequencing technology provides comprehensive analysis of the NOTCH3 gene, enabling early intervention and personalized management strategies for at-risk individuals and families.

What This Test Measures and Detects

This sophisticated genetic test specifically analyzes the NOTCH3 gene using cutting-edge NGS technology to identify pathogenic variants responsible for CADASIL. The test examines:

  • Complete sequencing of the NOTCH3 gene coding regions
  • Detection of cysteine-altering mutations in epidermal growth factor-like repeats
  • Identification of both known and novel genetic variants
  • Assessment of mutation pathogenicity and clinical significance
  • Comprehensive coverage of all 33 exons of the NOTCH3 gene

Who Should Consider This Important Genetic Test

This test is particularly recommended for individuals experiencing or concerned about:

  • Recurrent transient ischemic attacks or strokes before age 60
  • Unexplained migraines with aura, especially with neurological symptoms
  • Progressive cognitive decline or dementia in mid-adulthood
  • Family history of early-onset strokes or vascular dementia
  • White matter changes on brain MRI without clear explanation
  • Mood disorders or psychiatric symptoms with vascular risk factors
  • Multiple family members with similar neurological conditions

Significant Benefits of NOTCH3 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptom onset
  • Personalized Prevention: Implement targeted stroke prevention strategies
  • Family Planning: Make informed reproductive decisions with genetic counseling
  • Accurate Diagnosis: Differentiate CADASIL from other neurological conditions
  • Treatment Guidance: Optimize management approaches based on genetic findings
  • Family Screening: Identify at-risk relatives for proactive monitoring

Understanding Your Test Results

Your NOTCH3 genetic test results will fall into one of several categories:

  • Positive Result: Indicates a pathogenic NOTCH3 mutation associated with CADASIL. This confirms diagnosis and enables targeted management.
  • Negative Result: No disease-causing mutation detected, significantly reducing CADASIL likelihood.
  • Variant of Uncertain Significance: Identifies a genetic change with unknown clinical impact requiring further evaluation.
  • Carrier Status: Important for family members considering genetic testing.

All results include comprehensive interpretation by our genetic specialists and recommendations for next steps, including additional testing, monitoring, and family member screening when appropriate.

Test Pricing and Availability

Test Component Price (USD)
NOTCH3 Gene CADASIL NGS Genetic DNA Test – Discount Price $500
NOTCH3 Gene CADASIL NGS Genetic DNA Test – Regular Price $700

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic counselors and phlebotomy centers ensures accessible, professional care regardless of your location.

Take Control of Your Vascular Health Today

Don’t wait for symptoms to develop. Early genetic detection of CADASIL through NOTCH3 testing can significantly impact your long-term neurological health and quality of life. Our team of genetic specialists is ready to guide you through the testing process and provide comprehensive results interpretation.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your NOTCH3 Gene CADASIL NGS Genetic DNA Test and take the first step toward understanding your genetic risk for hereditary cerebral arteriopathy.

With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient. Remember to bring your clinical history and consider genetic counseling to create a family pedigree chart before your appointment for optimal testing outcomes.